Navigation Links
Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
Date:12/8/2007

tanespimycin, and from 0.7-1.3 mg/m2 for bortezomib. Activity was evaluated in patients that were bortezomib-naive, bortezomib-pretreated and bortezomib-refractory (defined as no response on prior bortezomib-containing regimens or progression on or within 60 days of a bortezomib-containing regimen). Patients received tanespimycin by a 1-hour infusion following the bortezomib dose 2 times per week every 2 weeks out of 3 weeks.

A total of 71 patients were enrolled in the trial: 30 patients in the dose-escalating phase and 41 patients treated at 340 mg/m2 of tanespimycin and 1.3 mg/m2 of bortezomib. Of the 41 patients in the 340 mg/m2 of tanespimycin and 1.3 mg/m2 of bortezomib dose group, 19 were treated with the prior Cremophor-containing formulation of tanespimycin (tanespimycin injection) and 22 were treated with the recently introduced tanespimycin injectable suspension formulation (52 evaluable total). As objective responses were observed across the multiple dose levels, the data at ASH were presented on an overall basis.

In the bortezomib-naive group, the overall response rate (complete, partial and minor responses) was 47% (9 out of 19 evaluable patients), including 2 complete responses (CR), 1 near-complete response, 2 partial responses (PR) and 4 minor responses (MR). The response rates were similar between the tanespimycin injection (45%, 5 out of 11 patients; 2 CR, 1 PR, 2 MR) and the injectable suspension (50%, 4 out of 8 patients; 1 CR, 1PR, 2 MR) groups.

In the bortezomib-pretreated group, the overall response rate was 47% (7 out of 15 evaluable patients; 1 CR, 2 PR, 4 MR). In this group, 14 patients received the Cremophor-containing formulation and 1 patient received the injectable suspension formulation.

In the bortezomib-refractory group, the overall response rate was 17% (3 out of 18 evaluable patients; 3 PR). All responding bortezomib-refractory patients received the Cremophor-containing formulation. Five patients receiv
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
2. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
3. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Kosan Presents Phase 1 Data Showing Antitumor Activity and Safety Profile of Epothilone KOS-1584 at AACR/NCI/EORTC Meeting
6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
7. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
8. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
9. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 Today, iHealth Lab Inc. announced it has ... for its first institutional round of funding. The strategic ... reach, accelerate growth and innovation, and invest in additional ... Xiaomi Ventures will join iHealth,s board of directors, bringing ... ecommerce. "We are very pleased to have ...
(Date:9/19/2014)... , September 19, 2014 ... has announced the addition of the ... to their offering.      (Logo: ... been broadly classified into wide categories based ... for the treatment of different gynecological conditions ...
(Date:9/19/2014)... Ill. , Sept. 19, 2014  The board ... ) declared a quarterly cash dividend of $0.42 per ... Nov. 17, 2014 to stockholders of record at the ... About AbbVie AbbVie is a global, research-based biopharmaceutical company ... mission is to use its expertise, dedicated people and ...
Breaking Medicine Technology:iHealth Raises $25 Million to Fuel Growth and Global Market Share 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 3
... 2011 Reportlinker.com announces that a new market ... Global Microscopes Industry ... the worldwide markets for Microscopes in US$ Million ... Microscopes, and Scanning Probe Microscopes. The report also ...
... StemCyte, Inc. announces the launch of www.cordbloodtv.com , ... offers this comprehensive educational tool that allows audiences worldwide ... blood banking options and the latest in medical research ... "StemCyte is pleased to offer our worldwide ...
Cached Medicine Technology:Reportlinker Adds Global Microscopes Industry 2Reportlinker Adds Global Microscopes Industry 3Reportlinker Adds Global Microscopes Industry 4Reportlinker Adds Global Microscopes Industry 5Reportlinker Adds Global Microscopes Industry 6Reportlinker Adds Global Microscopes Industry 7Reportlinker Adds Global Microscopes Industry 8Reportlinker Adds Global Microscopes Industry 9Reportlinker Adds Global Microscopes Industry 10Reportlinker Adds Global Microscopes Industry 11Reportlinker Adds Global Microscopes Industry 12Reportlinker Adds Global Microscopes Industry 13Reportlinker Adds Global Microscopes Industry 14Reportlinker Adds Global Microscopes Industry 15Reportlinker Adds Global Microscopes Industry 16Reportlinker Adds Global Microscopes Industry 17Reportlinker Adds Global Microscopes Industry 18Reportlinker Adds Global Microscopes Industry 19Reportlinker Adds Global Microscopes Industry 20Reportlinker Adds Global Microscopes Industry 21Reportlinker Adds Global Microscopes Industry 22StemCyte Launches CordBloodTV 2
(Date:9/20/2014)... 20, 2014 Ticket Down is ... tickets. This popular ticket exchange is offering their customer ... is nearing that next step in the entertainment business. The ... in the music and entertainment business, but is closing in ... straight No. 1 album, will hit the road next year ...
(Date:9/20/2014)... 19, 2014 (HealthDay News) -- The avian flu that ... could be spread through respiratory drops and therefore poses ... study. Although no human illnesses have been linked ... Children,s Research hospital have discovered natural mutations to the ... travel through the air in droplets. Current seasonal ...
(Date:9/20/2014)... York, New York (PRWEB) September 20, 2014 ... power morcellators ( http://www.injurybeacon.com/power-morcellator/ ) in gynecological ... that yet another insurer has announced plans to ... statement posted on its website last month, Harrisburg, ... procedures effective November 1, 2014. The insurer said ...
(Date:9/20/2014)... PA (PRWEB) September 20, 2014 "As a ... in their tanks," said an inventor from Tamaqua, Pa. "The ... mounted on the backs of their chairs. My invention enables ... developed the Kam Oxygen Sensor to make it easier to ... that the user knows when the tank is low. It ...
(Date:9/20/2014)... 2014 RBSEO Services, which has occupied ... has announced it provides an affordable website SEO (Search ... This announcement would benefit those new and old businesses ... cannot afford to pay a big amount for their ... their websites in top search results for their business ...
Breaking Medicine News(10 mins):Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 2Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 3Health News:Avian Flu In Harbor Seals Could Infect People 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 3Health News:RBSEO Services Announces Affordable Website SEO Service at Only $175 2
... CHICAGO Results of clinical research on new presbyopia treatments ... the United Stateswere reported in today,s Scientific Program of ... Ophthalmology (AAO) and Middle East-Africa Council of Ophthalmology ... comprehensive ophthalmic education conference and is in session October ...
... the world of business-performance experts and baseball talent scouts, ... to find a way to measure the productivity of ... findings the most recent issue of Science Translational ... contributions of individual scientists, judging the effectiveness of team ...
... By Serena Gordon HealthDay Reporter , MONDAY, ... average, untrained person can still save a life by focusing ... Heart Association. The simplified form of cardiopulmonary resuscitation, or ... -- and the oxygen in the blood -- flowing to ...
... HealthDay Reporter , MONDAY, Oct. 18 (HealthDay News) -- ... non-heart surgery had a higher risk of death in the ... found. And, patients who hadn,t been diagnosed with diabetes ... higher risk of death in the year after a surgical ...
... cancers can be divided into different subtypes based on ... protein to which the female hormone estrogen binds; that ... tumors have a worse outlook than those with ER-positive ... characterized as basal-like are the most aggressive and difficult ...
... American descent Latinas - from using cancer screening ... Dr. Linda Gallo from San Diego State University in ... are pessimistic about preventive health practices and disease outcomes ... breast and colorectal cancer. The research is published online ...
Cached Medicine News:Health News:New vision correction options for baby boomers 2Health News:New vision correction options for baby boomers 3Health News:New vision correction options for baby boomers 4Health News:Is team science productive? 2Health News:Is team science productive? 3Health News:New CPR Guidelines Emphasize Compressions First 2Health News:New CPR Guidelines Emphasize Compressions First 3Health News:Even Well-Controlled Diabetes May Present Post-Surgery Risk 2Health News:Even Well-Controlled Diabetes May Present Post-Surgery Risk 3Health News:Latinas: 'Cancer was just meant to be' 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: